Selecta: Selecta Biosciences merges with Cartesian Therapeutics
Selecta Biosciences, Inc. announced that it has merged with Cartesian Therapeutics, Inc., a clinical-stage biotechnology company pioneering RNA cell therapies for autoimmune diseases
Read full article »
CEO
Selecta is a Massachusetts-based biotechnology company that researches and develops immunotherapies for the treatment of autoimmune diseases.
Read more